Biotech Values

[DewDiligence]

>…what are these "events" given that later in the same sentence they say the DES had a lower rate?<

The events where BMS’s had a small, non-statsig advantage were deaths and non-fatal MI’s. The events where DES’s had a large advantage were TVR’s.

Agree that the article is poorly written. The most interesting aspect of it is the admonition favoring BMS’s for patients who can’t/won’t stay on Plavix.